It is a manufacturing private limited company based in Kanpur, Uttar Pradesh, India, established in 2005.
2005 | Kanpur, Uttar Pradesh, India | ActiveScorpio Biotechnology Private Limited, a active private limited company, was established on 20 September 2005 in Kanpur, Uttar Pradesh, India. Engaging in textile & fabric production within the manufacturing sector, it holds CIN: U24234UP2005PTC044055. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹2.62 Cr.
It upholds a compliant status. Its leadership includes Aman Kumar Agarwal (Director), Madhu Agarwal (Additional Director). Past directors included Ratan Lal Agarwal, Vikas Agarwal, Barsha Agarwal. It holds ₹26.30 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 19/X-1 Krishnapuram, G.T. Road, Kanpur, Uttar Pradesh, 208007.
U24234UP2005PTC044055
044055
20 September 2005
₹5.00 Cr
₹2.62 Cr
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Scorpio Biotechnology Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aman Kumar Agarwal | Director | 10 May 2024 | Current |
| Madhu Agarwal | Additional Director | 07 Mar 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 26 Sep 2017 | Past |
| Pramod Abcsdd | Director | 15 Jun 2017 | Past |
| Pramod Abcsdd | Director | 15 Jun 2017 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 07 Mar 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Scorpio Biotechnology Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 291458.76% decrease in profit. The company's net worth observed a substantial decline by a decrease of 79.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Scorpio Biotechnology had a public holding of 99.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹263,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 May 2014 | Syndicate Bank | ₹15.00 Cr | Open |
| 11 Mar 2014 | Central Bank Of India | ₹11.30 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Scorpio Biotechnology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Scorpio Biotechnology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scorpio Biotechnology's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Scorpio Biotechnology Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Aman Kumar Agarwal was appointed as a Director was appointed as a Director on 10 May 2024 & has been associated with this company since 1 year 7 months . was completed.
Scorpio Biotechnology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was recorded as a recent event.
The activity Madhu Agarwal was appointed as a Additional Director was appointed as a Additional Director on 07 Mar 2022 & has been associated with this company since 3 years 9 months . was completed.
A charge with Syndicate Bank amounted to Rs. 15.00 Cr with Charge ID 10509522 was registered on 26 May 2014. was recorded as a recent event.
A charge with Central Bank Of India amounted to Rs. 11.30 Cr with Charge ID 10487726 was registered on 11 Mar 2014. was recorded as a recent event.
The CIN of Scorpio Biotechnology Private Limited is U24234UP2005PTC044055.
Scorpio Biotechnology Private Limited is headquartered at 19/X-1 Krishnapuram, G.T. Road, Kanpur, Uttar Pradesh, 208007.
Scorpio Biotechnology Private Limited was incorporated on 20 September 2005.
The current directors of Scorpio Biotechnology Private Limited are
The primary industry of Scorpio Biotechnology Private Limited is Manufacturing.
Scorpio Biotechnology Private Limited is unlisted.
The authorized capital of Scorpio Biotechnology Private Limited is ₹5.00 Cr, and the paid-up capital is ₹2.62 Cr.
The compliance status of Scorpio Biotechnology Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX